Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
根据最新的财务报表(Form-10K),Alpha Tau Medical Ltd 的总资产为 $0,净亏损为 $0
DRTS 的关键财务比率是什么?
Alpha Tau Medical Ltd 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Alpha Tau Medical Ltd 的收入按细分市场或地理位置如何划分?
Alpha Tau Medical Ltd 最大收入来源是 Human Mesenchymal and Other Stem Cell and Cell-derived Products,在最近的收益报告中收入为 48,900。就地区而言, China 是 Alpha Tau Medical Ltd 的主要市场,收入为 48,900。